RETRACTED: The role of fenhexamid on the proliferation of ovarian cancer BG-1 cells (Retracted Article)

被引:0
|
作者
Fei, Anxing [1 ]
Fu, Handong [3 ]
Jiang, Hong [1 ,4 ]
Wei, Liping [1 ]
Zhang, Hongxia [1 ]
Fei, Anqiong [2 ]
Zhang, Yan [1 ]
Zou, Tiantian [1 ]
Gao, Shuzhen [1 ]
Li, Lin [4 ]
Jiang, Hong [1 ,4 ]
Zhou, Min [4 ]
Xing, Hui [4 ]
Huang, Yanli [4 ]
机构
[1] Huangshi Maternal & Child Hlth Hosp, Clin Lab, Lab Dept, Huangshi 435000, Hubei, Peoples R China
[2] Daye Gen Hosp, Huangshi 435100, Hubei, Peoples R China
[3] Wuhan Univ Sci & Technol, Xiaogan Hosp, Xiaogan 432100, Hubei, Peoples R China
[4] Hubei Univ Arts & Sci, Xiangyang Cent Hosp, Dept Obstet & Gynecol, Xiangyang 441021, Hubei, Peoples R China
关键词
Ovarian cancer; fenhexamid; pesticide residues; ESTROGEN-RECEPTOR-ALPHA; DEPENDENT SIGNALING PATHWAY; BISPHENOL-A; GROWTH; TRICLOSAN; MODELS; GENES;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To study the influence of fenhexamid in pesticide residue to the human ovarian cancer BG-1 cell proliferation. Detecting the effectiveness of 17 beta-estradiol, fenhexamid and Fulvestrant to BG-1 cell proliferation by MTT, and detecting the expression levels of cyclin D1 and cyclin E by Western blot. Fenhexamid can promote BG-1 cell proliferation for its estrogen-like effect. On the other hand, it can help to improve the expression levels of cyclin D1 and cyclin E in BG-1 cells which is regulated by ER-dependent pathway. And 17 beta-estradiol is also regulated by the same way. The existence of fenhexamid can promote ovarian cancer cell proliferation, so for patients with ovarian cancer, fenhexamid in pesticide residue may make medical conditions worse.
引用
收藏
页码:2025 / 2031
页数:7
相关论文
共 50 条
  • [31] RETRACTED: Knockdown of lncRNA FOXD2-AS1 Inhibits Proliferation, Migration, and Drug Resistance of Breast Cancer Cells (Retracted Article)
    Nong, Qiaohong
    Yu, Shaokang
    Hu, Hui
    Hu, Xue
    COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE, 2021, 2021
  • [32] RETRACTED: IFIT1 modulates the proliferation, migration and invasion of pancreatic cancer cells via Wnt/β-catenin signaling (Retracted Article)
    Li, Tian-Hao
    Zhao, Bang-Bo
    Qin, Cheng
    Wang, Yuan-Yang
    Li, Ze-Ru
    Cao, Hong-Tao
    Yang, Xiao-Ying
    Zhou, Xing-Tong
    Wang, Wei-Bin
    CELLULAR ONCOLOGY, 2021, 44 (06) : 1425 - 1437
  • [33] RETRACTED: An Image Recognition Framework for Oral Cancer Cells (Retracted Article)
    Zhang, Hao
    Li, Wei
    Zhang, Hanzhong
    JOURNAL OF HEALTHCARE ENGINEERING, 2021, 2021
  • [34] RETRACTED: Myosin VI contributes to malignant proliferation of human glioma cells (Retracted Article)
    Xu, Rong
    Fang, Xu-hao
    Zhong, Ping
    KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY, 2016, 20 (02): : 139 - 145
  • [35] RETRACTED ARTICLE: Targeted immune therapy of ovarian cancer
    Keith L. Knutson
    Lavakumar Karyampudi
    Purushottam Lamichhane
    Claudia Preston
    Cancer and Metastasis Reviews, 2015, 34 (1) : 53 - 74
  • [36] RETRACTED: Long noncoding RNA PCAT-1 promoted ovarian cancer cell proliferation and invasion by suppressing KLF6 (Retracted Article)
    Liu, H-P
    Lv, D.
    Wang, J-Y
    Zhang, Y.
    Chang, J-F
    Liu, Z-T
    Tang, N.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (11) : 4650 - 4655
  • [37] RETRACTED: RNA-based immunotherapy of cancer: role and therapeutic implications of dendritic cells (Retracted Article)
    Tyagi, Rajeev K.
    Mangal, Sharad
    Garg, Neeraj
    Sharma, Pradeep K.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (01) : 97 - 114
  • [38] RETRACTED: Long noncoding RNA LINP1 promoted proliferation and invasion of ovarian cancer via inhibiting KLF6 (Retracted Article)
    Li, Y.
    Hou, C-Z
    Dong, Y-L
    Zhu, L.
    Xu, H.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (01) : 36 - 42
  • [39] RETRACTED: Immature Colon Carcinoma Transcript 1 Is Essential for Prostate Cancer Cell Viability and Proliferation (Retracted Article)
    Wang, Zhijun
    Xu, Danfeng
    Gao, Yi
    Liu, Yushan
    Ren, Jizhong
    Yao, Yacheng
    Yin, Lei
    Chen, Jie
    Gan, Sishun
    Cui, Xingang
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2015, 30 (07) : 278 - 284
  • [40] RETRACTED: MicroRNA-363 inhibits ovarian cancer progression by inhibiting NOB1 (Retracted Article)
    Lin, Yang
    Xu, Tianmin
    Zhou, Shunqing
    Cui, Manhua
    ONCOTARGET, 2017, 8 (60) : 101649 - 101658